Casma Therapeutics
Biotechnology ResearchMassachusetts, United States11-50 Employees
We're harnessing the natural cellular process of autophagy to design powerful new medicines for a broad range of diseases.
Funding Strength Casma Therapeutics has received significant funding injections totaling $150.5 million. This financial backing signifies the company's growth potential, which may present partnership or investment opportunities for businesses in the biotechnology sector.
Cutting-Edge Research Casma Therapeutics focuses on leveraging autophagy for developing innovative treatments across cancer, inflammation, neurodegeneration, and metabolic disorders. This unique approach showcases the company's commitment to pioneering research, opening doors for collaboration with firms seeking groundbreaking therapeutic solutions.
Expansion in Expertise The recent appointment of a seasoned professional like Dr. Sharon Tooze to Casma Therapeutics' scientific advisory board signifies the company's drive towards expanding its knowledge base. This move could be leveraged by companies aiming to tap into the insights of industry experts for collaborative ventures.
Strategic Partnerships With investments from prominent entities like Third Rock Ventures and The Column Group, Casma Therapeutics showcases strategic collaboration opportunities. Businesses looking to align with established industry players could explore avenues for partnerships or joint ventures with Casma Therapeutics.
Market Visibility Casma Therapeutics' progress and funding rounds have garnered attention from media outlets like ExploreBit, equities.com, and BusinessWire. Leveraging the company's visibility through press coverage could be beneficial for sales and BD professionals seeking to leverage industry presence for networking or business opportunities.
Casma Therapeutics uses 8 technology products and services including WordPress, MySQL, Font Awesome, and more. Explore Casma Therapeutics's tech stack below.
Casma Therapeutics Email Formats | Percentage |
Biotechnology ResearchMassachusetts, United States11-50 Employees
We're harnessing the natural cellular process of autophagy to design powerful new medicines for a broad range of diseases.
Casma Therapeutics has raised a total of $46M of funding over 4 rounds. Their latest funding round was raised on Nov 15, 2022 in the amount of $46M.
Casma Therapeutics's revenue is in the range of $10M
Casma Therapeutics has raised a total of $46M of funding over 4 rounds. Their latest funding round was raised on Nov 15, 2022 in the amount of $46M.
Casma Therapeutics's revenue is in the range of $10M